William (Bill) Grey
PhD at King's College London (with the late Dr Veronica Yu and Prof. David Grimwade) on CKS1/CKS2-controlled proteostasis across stem cell systems. Postdoc with Prof. Dominique Bonnet at the Francis Crick Institute, working on the HSC kinome, ex vivo HSC expansion, and CKS1-dependent proteostasis in AML. Now leads ProteoStem, funded by an MRC Career Development Award and others.
Anjum Khan
Consultant haematologist holding an MRC Clinical Academic Research Partnership award to lead joint projects with the lab. Research interests in AML and myeloid malignancies, allogeneic stem cell transplantation, and immunotherapy, with a focus on the mechanisms driving leukaemic stem cells and chemotherapy resistance.
Juliana Fabiani Miranda
PhD from the University of Liverpool in immuno-oncology, targeting a macrophage-derived molecule shaping the metastatic pancreatic-cancer microenvironment. Joined the Grey Lab in May 2023 to study how protein homeostasis modulates AML development and relapse.
Megan Guthrie
BSc from Warwick and MRes in Biomedical Sciences and Translational Medicine from Liverpool, working on aberrantly expressed meiotic proteins in cancer. Began her MRC-DiMeN PhD in the lab in October 2023, investigating human HSC biology and ex vivo expansion.
William Critchley
PhD in Immunology from Manchester (2017) on the passenger leukocyte reservoir in solid organ transplantation, followed by BHF-funded postdoctoral work in the Ponnambalam lab at Leeds on the post-translational control of VEGFR2. Joined the Grey Lab in April 2024 to study proteostatic vulnerabilities in human LSCs.
Kimrun Kaur
BSc and MRes from UWE Bristol on non-genotoxic therapeutics in multiple myeloma, followed by research-technician work in the Healthcare Associated Infection Research group modelling C. difficile infection. Holds a YGRS-funded PhD in the lab, investigating the protein biology of multiple myeloma at diagnosis and relapse.
Daniel Davies
BSc in Molecular and Cellular Biology from Glasgow and an MSc in Bioinformatics from Edinburgh, integrating microarray, RNA-seq and ChIP-seq data to map OCT4 binding during embryonic stem cell differentiation, and has since worked on ageing and rejuvenation of blood stem cells using in vivo CRISPR screening at the University of Helsinki. Started an NC3Rs-funded PhD in the lab in 2025, combining single-cell transcriptomics, surface-protein profiling and bulk proteomics to define leukaemic stem cell populations that drive relapse in paediatric AML, with the aim of replacing mouse transplant models with in silico and in vitro approaches that sustain LSC properties long term in culture.
Anna Scott
MSci in Biomedical Sciences from the University of York, working on single-cell characterisation of paediatric AML. Awarded an N8 CIR studentship to develop an R Shiny toolkit for interactive processing of proteomic datasets. Continued as a Technician in the Grey lab, developing machine-learning approaches for blood cancer subtype classification.
Jenny Derrick
Completed an MRes in Immunobiology at Newcastle University, investigating the cellular consequences of disease-associated RAG1 variants in severe combined immunodeficiency (SCID). Joined the Grey Lab for her PhD in 2026 as part of the DiMeN programme to explore how harnessing proteostasis can enhance blood stem cell expansion for bone marrow transplantation.
Martyna Borkowska
MD from the Medical University of Lodz, Poland, with previous research experience in translational oncology and molecular cancer biology. Began her MRC DiMeN PhD in the lab in October 2026, investigating the mechanisms underlying therapy resistance in leukaemic stem cells in acute myeloid leukaemia.
